prostatic neoplasms, castration-resistant Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Male only (2)

Phase 1 (1)
Phase 1/2 (1)

Interventional (2)

Arcus Biosciences, Inc. (1)
Poseida Therapeutics, Inc. (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadmeasurable disease

I am/have/hadmetastatic castration-resistant prostate cancer

I am/have/hadmetastatic hormone refractory prostate cancer

I am/have/hadcancer

I am/have/hadcombination therapy

I am/have/hadprostatic neoplasm

I am/have/hadprostatic neoplasms, castration-resistant

I am/have/hadcastration-resistant prostate cancer

I am/have/hadmetastasis

I am/have/hadmetastatic disease

I am/have/hadprostate cancer

I am/have/hadcombined modality therapy

I am/have/hadmetastatic cancer

added new label for I am/have/had

I am looking for

I am looking fortestosterone

I am looking forenzalutamide

I am looking fordocetaxel

I am looking fortaxane

I am looking forantiandrogen therapy

I am looking forrimiducid

I am looking forantiandrogens

added new label for I am looking for

Advanced Filters

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Multi-country trial
Phase 1
For Seniors
For adults
Recruiting in 100s
Interventional Study
For Males
Family Medicine
Recruiting

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

testosterone

measurable disease

enzalutamide

prostatic neoplasm

combination therapy

0 views
19 Feb, 2024
22 locations

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
For Males
Family Medicine
Recruiting

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC.

measurable disease

metastatic castration-resistant prostate cancer

metastatic hormone refractory prostate cancer

cancer

rimiducid

0 views
19 Feb, 2024
3 locations